Selinexor in Combination With Thalidomide and Dexamethasone in RRMM

Clinical trial NCT04891744 · UNKNOWN

Trial details

NCT number: NCT04891744
Sponsor: Li Zheng
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2021-07-06
Primary completion: 2024-12-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.